Condition: Postoperative Pain · Sponsor: Rutgers, The State University of New Jersey
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following pediatric tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage.Participants will: Undergo tonsillectomy procedure. Receive and fill out a survey sent via email every 2 days following their procedure for 15 days, plus an additional survey on day 30, and track their symptoms.
This description comes directly from the study's public registry record.
Wayne D Hsueh, MD · 973-972-4588 · wayne.hsueh@rutgers.edu
Gabriel Frimpong, MPH, PA · 973-972-2309 · gf345@njms.rutgers.edu
Always discuss trial participation with your own doctor first.
| Cooperman Barnabas Medical Center | Livingston, New Jersey, United States | Not Yet Recruiting |
| University Hospital | Newark, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07188779